Security
Veradermics, Incorporated · MANE
MANENYSECommon stockCurrentCIK 1827635Updated Oct 20, 2026
MANE price & chart
Loading TradingView…
NYSE:MANE on TradingView ↗About the company
We are a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for pattern hair loss, or PHL, a condition affecting approximately 50 million men and 30 million women in the United States. Current PHL treatment options are limited and therefore are consistently plagued with high rates of treatment failure, patient dissatisfaction and treatment discontinuation. Patients and healthcare providers routinely identify the following shortcomings with currently available treatment options:
In the news
No coverage from other publishers is available.
Recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
SCHEDULE 13G - filed by JPMORGAN CHASE & CO regarding Veradermics, Inc
3 filing
144 filing
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| AssetsUSD | 825,735,000Source | — | 397,356,000Source | — | 152,619,000Source | 55,535,000Source |
| Property, Plant and Equipment, NetUSD | 41,000Source | — | 21,000Source | — | 22,000Source | 0Source |
| Current assets: | ||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 319,333,000Source | — | 168,412,000Source | — | 21,766,000Source | 53,084,000Source |
| Assets, CurrentUSD | 824,746,000Source | — | 397,069,000Source | — | 152,494,000Source | 55,535,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,852,000Source | — | 6,272,000Source | — | 10,632,000Source | 2,451,000Source |
| Operating Lease, Right-of-Use AssetUSD | 948,000Source | — | 266,000Source | — | 103,000Source | 0Source |
| LIABILITIES AND EQUITY | ||||||
| LiabilitiesUSD | 12,122,000Source | — | 6,716,000Source | — | 9,156,000Source | 4,718,000Source |
| Stockholders’ equity: | ||||||
| Common Stock, Value, IssuedUSD | 1,000Source | — | 1,000Source | — | 1,000Source | 1,000Source |
| Additional Paid in CapitalUSD | 989,258,000Source | — | 543,044,000Source | — | 2,346,000Source | 750,000Source |
| Retained Earnings (Accumulated Deficit)USD | -174,155,000Source | — | -150,653,000Source | — | -123,421,000Source | -49,231,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -895,000Source | — | -524,000Source | — | 60,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 813,613,000Source | -76,072,000Source | 390,640,000Source | -60,667,000Source | -121,014,000Source | -48,480,000Source |
| Liabilities and EquityUSD | 825,735,000Source | — | 397,356,000Source | — | 152,619,000Source | 55,535,000Source |
| Current liabilities: | ||||||
| Liabilities, CurrentUSD | 11,694,000Source | — | 6,716,000Source | — | 9,152,000Source | 4,718,000Source |
| Accounts Payable, CurrentUSD | 5,920,000Source | — | 1,071,000Source | — | 2,126,000Source | 2,248,000Source |
| Operating Lease, Liability, NoncurrentUSD | 428,000Source | — | 0Source | — | 4,000Source | 0Source |
| Additional Financial Items | ||||||
| Accrued Liabilities, CurrentUSD | 5,395,000Source | — | 5,606,000Source | — | 6,979,000Source | 2,470,000Source |
| Preferred Stock, Value, Issued | —Source | — | —Source | — | — | — |
| Cash, Cash Equivalents, and Short-term Investments | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 5,259,000Source | 213,000Source | 1,440,000Source | 250,000Source |
| Changes in operating assets and liabilities: | ||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | -1,055,000Source | -686,000Source | -122,000Source | 646,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | -21,168,000Source | -13,317,000Source | -71,602,000Source | -23,688,000Source |
| Cash flows from investing activities: | ||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -101,299,000Source | -15,750,000Source | -118,858,000Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | 0Source | 19,000Source | 24,000Source | 0Source |
| Cash flows from financing activities: | ||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | 269,113,000Source | 8,423,000Source | 159,142,000Source | 60,476,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | 146,646,000Source | -20,644,000Source | -31,318,000Source | 36,788,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 319,333,000Source | 8,596,000Source | 168,412,000Source | 32,440,000Source | 21,766,000Source | 53,084,000Source |
| Supplemental disclosure of cash flow information: | ||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | 0Source | 95,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | 0Source | 0Source |
| Additional Financial Items | ||||||
| Share-based Payment Arrangement, ExpenseUSD | 3,516,000Source | 115,000Source | 5,259,000Source | 213,000Source | 1,440,000Source | 250,000Source |
| General and Administrative ExpenseUSD | 10,946,000Source | 1,744,000Source | 8,937,000Source | 1,468,000Source | 10,282,000Source | 3,495,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | — | — | 0Source | 585,000Source |
| Investment Income, InterestUSD | 4,838,000Source | 103,000Source | 2,481,000Source | 482,000Source | 1,562,000Source | 481,000Source |
| Net Income (Loss) Attributable to ParentUSD | -23,502,000Source | -15,645,000Source | -27,232,000Source | -12,400,000Source | -69,995,000Source | -26,488,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -23,502,000Source | -18,014,000Source | -30,011,000Source | -14,582,000Source | -83,373,000Source | -27,303,000Source |
| Nonoperating Income (Expense)USD | 6,051,000Source | 428,000Source | 2,630,000Source | 515,000Source | 2,352,000Source | 290,000Source |
| Operating ExpensesUSD | 29,553,000Source | 16,073,000Source | 29,862,000Source | 12,915,000Source | 72,347,000Source | 26,778,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 11,000Source | 0Source | 156,000Source | 0Source |
| Cash, Cash Equivalents, and Short-term Investments | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | -29,553,000Source | -16,073,000Source | -29,862,000Source | -12,915,000Source | -72,347,000Source | -26,778,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -23,502,000Source | -15,645,000Source | -27,232,000Source | -12,400,000Source | -69,995,000Source | -26,488,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -23,502,000Source | -15,645,000Source | -27,232,000Source | -12,400,000Source | -69,995,000Source | -26,488,000Source |
| Earnings Per Share, BasicUSD per share | -0.58Source | -24.19Source | -1.32Source | -19.79Source | -111.91Source | -37.05Source |
| Earnings Per Share, DilutedUSD per share | -0.58Source | -24.19Source | -1.32Source | -19.79Source | -111.91Source | -37.05Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 40,436,264Source | 744,641Source | 22,704,124Source | 736,933Source | 744,991Source | 736,933Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 40,436,264Source | 744,641Source | 22,704,124Source | 736,933Source | 744,991Source | 736,933Source |
| Interest Expense (non-operating)USD | — | — | — | — | 0Source | 585,000Source |
| Additional Financial Items | ||||||
| General and Administrative ExpenseUSD | 10,946,000Source | 1,744,000Source | 8,937,000Source | 1,468,000Source | 10,282,000Source | 3,495,000Source |
| Investment Income, InterestUSD | 4,838,000Source | 103,000Source | 2,481,000Source | 482,000Source | 1,562,000Source | 481,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -23,502,000Source | -18,014,000Source | -30,011,000Source | -14,582,000Source | -83,373,000Source | -27,303,000Source |
| Nonoperating Income (Expense)USD | 6,051,000Source | 428,000Source | 2,630,000Source | 515,000Source | 2,352,000Source | 290,000Source |
| Operating ExpensesUSD | 29,553,000Source | 16,073,000Source | 29,862,000Source | 12,915,000Source | 72,347,000Source | 26,778,000Source |
| Research and Development ExpenseUSD | 18,607,000Source | 14,329,000Source | 20,925,000Source | 11,447,000Source | 62,065,000Source | 23,283,000Source |
Offerings
Registration 333-298150
Registration 333-295356
- Gross proceeds
- 384379000.0
- Net proceeds
- 361316260.0
- Deal price
- 100.0
- Shares
- 3843790
- Offering price
- $100.00
- Ticker
- MANE
Underwriters: Jefferies LLC, Leerink Partners LLC, Citigroup Global Markets Inc., Needham & Company, LLC
Registration 333-295420
Registration 333-292657
- Gross proceeds
- 256319999.0
- Net proceeds
- 238377599.0
- Deal price
- 17.0
- Shares
- 15077647
- Offering price
- $17.00
- Ticker
- MANE
Underwriters: Jefferies LLC, Leerink Partners LLC, Citigroup Global Markets Inc.